Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Polyamine enhanced formulations for triptan compound iontophoresis

An iontophoresis, compound technology, applied in the direction of electrotherapy, active ingredients of heterocyclic compounds, medical preparations of non-active ingredients, etc.

Inactive Publication Date: 2014-06-25
TEVA PHARMACEUTICALS INTERNATIONAL GMBH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

A notable limitation of the device is the two-component construction of the delivery system; the wire connection between the controller and the patch is cumbersome to the wearer
Furthermore, programmable controllers can be expensive if exploited on a single-use basis, or, if exploited on a repeated-use basis, programmable controllers can be lost, contaminated, damaged, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polyamine enhanced formulations for triptan compound iontophoresis
  • Polyamine enhanced formulations for triptan compound iontophoresis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0095] Example 1: Use of patches for iontophoresis delivery of sumatriptan succinate

[0096] A single-center, open label, single-dose, five-period study was conducted to compare the pharmacokinetics of the four prototypes of the transdermal patch for sumatriptan iontophoresis of the present invention in healthy volunteers. Comparison of 100 mg oral sumatriptan succinate. The subject must at least participate in treatment A and treatment B.

[0097] The iontophoresis patch used comes with an external power source and is designed to be applied to the skin surface and deliver drugs throughout the body.

[0098] The patch treatment and the prototype iontophoresis patch prepared for this example are detailed in Table 2 below.

[0099] Table 2 Quantitative treatment with patches for iontophoresis

[0100]

[0101] Nine subjects participated in treatment B, 100 mg sumatriptan succinate oral tablets. The study consisted of follow-up screening after treatments A, B, C, D, and E. Each treat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A patch and compositions for iontophoresis of triptan compounds are described.

Description

Technical field [0001] This application claims the priority of US application serial number 12 / 214,555 filed on June 19, 2008, the entire content of which is hereby incorporated by reference. Background technique [0002] The method of iontophoresis (iontophoresis) was described by LeDuc in 1908, so it has found commercial use in the delivery of ionically charged therapeutic agent molecules such as pilocarpine, lidocaine and dexamethasone. In this delivery method, positively charged ions are driven through the skin at the anode position of the electrolysis system, while negatively charged ions are driven through the skin at the cathode position of the electrolysis system. [0003] In the early days, and now, iontophoresis devices typically consisted of two electrodes affixed to the patient by an adhesive material, each connected to a remote power source by a wire, usually an electrical instrument controlled by a microprocessor. [0004] Recent publications indicate that sumatriptan ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61F13/00A61K9/70A61K31/40
CPCA61K9/7023A61K9/0009A61N1/30A61K31/4045A61P25/06A61K47/12A61K47/32A61K47/34A61N1/303
Inventor T·B·塞布里M·霍斯特曼M·萨米提
Owner TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products